Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trial
Pengfei Jin(Jiangsu Provincial Center for Disease Control and Prevention), Jingxin Li(Shandong University), Zhuopei Li(Nanjing Medical University), Gao Chunjing(Jiangsu University), Mingdong Ding(Nantong University), Limei Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Hongmei Jiang(Shandong First Medical University), Qiao Liu(Jiangsu Provincial Center for Disease Control and Prevention), Siyue Jia(Jiangsu Provincial Center for Disease Control and Prevention), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Mingwei Wei(Jiangsu Provincial Center for Disease Control and Prevention), Rui-Mei Zhang(Jiangsu University), Yuansheng Hu(Sinovac Biotech), Xilin Guo(Jiangsu Provincial Center for Disease Control and Prevention), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Jianfeng Wang(Xi’an Jiaotong-Liverpool University), Wen‐Li Chen(Harbin Institute of Technology), Li Zhou(Central South University), Zhao-Lan Cao(The First People’s Hospital of Lianyungang), Xiaoyin Zhang(Southeast University), Kui Zhang(Chinese Academy of Sciences), Xin Xia(Nanjing Medical University), Yanfei Wu(Fudan University), Jia He(Xinjiang Uygur Autonomous Region Disease Prevention and Control Center), Yawen Zhu(Nanjing Medical University), Tiantian Zhang(University of Jinan), Gang Zeng(Sinovac Biotech)
Cited by 0
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Double-negative-index ceramic aerogels for thermal superinsulation
|Science|2019|756
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268